Novel peptides as NS3-serine protease inhibitors of hepatitis C virus
Details for Australian Patent Application No. 2009210423 (hide)
International Classifications
Event Publications
10 September 2009 Complete Application Filed
17 September 2009 Application Open to Public Inspection
Published as AU-A-2009210423
4 October 2012 Alteration of Name
The name of the applicant has been altered to Dendreon Corporation; Merck Sharp & Dohme Corp.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser